Latest Contracts News

Santos Limited reported robust operational and financial results for Q2 2025, driven by solid production and cash flow, while its flagship Barossa LNG and Pikka projects advance on schedule. The company also navigates flood impacts and a notable acquisition proposal.

Conrad Asia Energy has inked a binding gas sales agreement with Indonesia’s PLN EPI for the entire output of its Mako Gas Field, marking a pivotal step towards production and domestic market integration.

IDT Australia has signed a memorandum with NASDAQ-listed Gelteq to establish a dedicated gel-based product manufacturing facility, marking a strategic expansion in pharmaceutical delivery technologies.

MLG Oz Limited has locked in a new two-year contract with Fortescue subsidiaries to provide crushing and screening services at multiple Western Australian mine sites, reinforcing its foothold in the mining services sector.

Visionflex Group delivered a standout Q4 FY25, posting $2.1 million in cash receipts and securing transformative contracts that underpin its expanding virtual healthcare footprint.

Integrated Research reports a softer FY25 with declines in contract value and earnings, yet steady underlying revenue and promising AI-driven product launches signal a strategic pivot.

Rox Resources has made significant strides in advancing its Youanmi Gold Project, backed by a $40 million capital raise and promising drilling results that underpin an imminent resource update and feasibility study.

Australian Vintage Ltd is accelerating its inventory reduction by exiting the Millewa Vineyard lease early, unlocking over $8 million in net cash flow benefits and reshaping its grape sourcing strategy.

Lumos Diagnostics Holdings Limited has had its ASX trading suspension lifted following news of a strategic material agreement, signaling potential growth ahead.

Lumos Diagnostics has inked a landmark six-year exclusive distribution agreement with PHASE Scientific for its FebriDx® rapid diagnostic test in the US, potentially unlocking nearly half a billion Australian dollars in revenue contingent on FDA approval.

ImpediMed has doubled its US unit sales in Q4 FY25, achieving a record total contract value and securing an additional $5 million tranche under its growth capital facility.

Javelin Minerals has announced a significant 27% increase in the Indicated Resource at its Eureka Gold Project in Western Australia, alongside a 16% grade improvement, setting the stage for expanded near-term mining plans.